Coronavirus transmission risk increases along wildlife supply chains

10-Aug-2020 2:05 PM EDT, by PLOS

Newswise — Coronaviruses were detected in a high proportion of bats and rodents in Viet Nam from 2013 to 2014, with an increasing proportion of positive samples found along the wildlife supply chain from traders to large markets to restaurants, according to a study published August 10 in the open-access journal PLOS ONE by Amanda Fine of the Wildlife Conservation Society and colleagues. As noted by the authors, the amplification of coronaviruses along the wildlife supply chain suggests maximal risk for end consumers and likely explains the coronavirus spillover to people.

Outbreaks of emerging coronaviruses in the past two decades and the current pandemic of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) highlight the importance of this viral family as a public health threat. Human-wildlife contact with a bat or an intermediate host species in China almost certainly triggered a coronavirus spillover event that may have involved wildlife markets and led to the pandemic spread of SARS-CoV-2, according to the latest scientific evidence. Beyond China, commercial wildlife farming in Viet Nam is part of the expanded international wildlife trade that is thought to contribute to global epidemics, such as SARS and now coronavirus disease 2019 (COVID-19), which is caused by SARS-CoV-2.

To better understand the natural hosts of coronaviruses and the risk for these wildlife-human interfaces to facilitate spillover into humans, Fine and her collaborators investigated presence of viruses in the coronavirus family and diversity in wildlife at wildlife-human interfaces in Viet Nam from 2013 to 2014 (years prior to the emergence of SARS-CoV-2).

They observed high proportions of positive samples of coronaviruses among field rats (34.0%, 239/702) destined for human consumption and bats in guano farms (74.8%, 234/313) adjacent to human dwellings. The odds of coronavirus detection increased along the supply chain, from field rats sold by traders (20.7%, 39/188), to field rats sold in large markets (32.0%, 116/363), and field rats served in restaurants (55.6%, 84/151). Coronaviruses were also detected in rodents on most wildlife farms sampled (60.7%, 17/28), affecting Malayan porcupines (6.0%, 20/331) and bamboo rats (6.3%, 6/96) raised for human consumption. To minimize the public health risks of viral disease emergence, the authors recommend improving coronavirus surveillance in wildlife and implementing targeted wildlife trade reform. 

The authors add: “This study shows the wildlife supply chain generates a one-two punch when it comes to spillover risk. It is known to increase contact rates between wildlife and people and here we show how it greatly amplifies the number of infected animals along the way.”

#####

Press-only preview: https://plos.io/3isH49P 

Image Caption: Fig 2. Malayan porcupine (Hystrix brachyura) farm in Dong Nai province, November 2013. 

Image Credit: Huong et al, 2020 (PLOS ONE, CC BY)

Citation: Huong NQ, Nga NTT, Long NV, Luu BD, Latinne A, Pruvot M, et al. (2020) Coronavirus testing indicates transmission risk increases along wildlife supply chains for human consumption in Viet Nam, 2013-2014. PLoS ONE 15(8): e0237129https://doi.org/10.1371/journal.pone.0237129

 

Funding: This study was made possible by the generous support of the American people through the United States Agency for International Development (USAID) Emerging Pandemic Threats PREDICT project (cooperative agreement numbers GHN-A-OO-09-00010-00 [J.A.K.M., C.K.J., T.G., D.O.J.] and AID-OAA-A-14-00102 [J.A.K.M, C.K.J., T.G., A.E.F, S.H.O.]). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. The URL to the USAID Emerging Pandemic Threats Program (EPT-1 and 2) is https://www.usaid.gov/ept2.

 

Competing Interests: The authors have declared that no competing interests exist.

 

In your coverage please use this URL to provide access to the freely available article in PLOS ONE https://journals.plos.org/plosone/article?id=10.1371/journal.pone.0237129

SEE ORIGINAL STUDY




Filters close

Showing results

110 of 3321
Newswise: 243389_web.jpg
Released: 18-Sep-2020 10:55 AM EDT
Potential new drug to mitigate SARS-CoV-2 infection consequences
University of Malaga

Scientists from the Department of Cell Biology of the University of Malaga (UMA) and the Andalusian Centre for Nanomedicine and Biotechnology (BIONAND) have made progress in finding new rapid implementation therapies to combat the COVID-19 pandemic, identifying a new drug that could prevent or mitigate the consequences derived from SARS-CoV-2 infection.

Newswise: 243400_web.jpg
Released: 18-Sep-2020 10:40 AM EDT
Most homemade masks are doing a great job, even when we sneeze, study finds
University of Illinois at Urbana-Champaign

Studies indicate that homemade masks help combat the spread of viruses like COVID-19 when combined with frequent hand-washing and physical distancing.

access_time Embargo lifts in 2 days
Embargo will expire: 23-Sep-2020 8:00 AM EDT Released to reporters: 18-Sep-2020 10:00 AM EDT

A reporter's PressPass is required to access this story until the embargo expires on 23-Sep-2020 8:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 18-Sep-2020 8:30 AM EDT
Immunotherapy Drug Development Pipeline Continues Significant Growth in 2020 Despite Global Pandemic Impact
Cancer Research Institute

Despite the impact of the COVID-19 pandemic across the globe, there has been a resurgence of interest in immuno-oncology (I-O) preclinical and clinical development, bringing hope to cancer patients and physicians who treat them.

Released: 17-Sep-2020 5:50 PM EDT
AERA and OECD to Co-Host Webinar on Education Research Worldwide in a Covid and Post-Covid World
American Educational Research Association (AERA)

The American Educational Research Association (AERA) and the Organisation for Economic Co-operation and Development (OECD) will co-host a webinar on “Education Research Worldwide in a Covid and Post-Covid World” at 9:30-11:00 am EDT Wednesday, September 23.

Newswise: 243232_web.jpg
Released: 17-Sep-2020 4:20 PM EDT
Study shows first proof that a safer UV light effectively kills virus causing COVID-19
Hiroshima University

A study conducted by Hiroshima University researchers found that using Ultraviolet C light with a wavelength of 222 nanometers which is safer to use around humans effectively kills SARS-CoV-2 -- the first research in the world to prove its efficacy against the virus that causes COVID-19.

Newswise:Video Embedded american-academy-of-dermatology-honors-detroit-physician-iltefat-h-hamzavi-with-national-patient-care-hero-award
VIDEO
Released: 17-Sep-2020 4:00 PM EDT
American Academy of Dermatology honors Detroit physician Iltefat H. Hamzavi with national “Patient Care Hero” award
American Academy of Dermatology

The American Academy of Dermatology has named board-certified dermatologist Iltefat H. Hamzavi, MD, FAAD, a Patient Care Hero for his innovative use of light therapy to sanitize masks needed by frontline health care workers.

access_time Embargo lifts in 2 days
Embargo will expire: 22-Sep-2020 11:00 AM EDT Released to reporters: 17-Sep-2020 3:20 PM EDT

A reporter's PressPass is required to access this story until the embargo expires on 22-Sep-2020 11:00 AM EDT The Newswise PressPass gives verified journalists access to embargoed stories. Please log in to complete a presspass application. If you have not yet registered, please Register. When you fill out the registration form, please identify yourself as a reporter in order to advance to the presspass application form.

Released: 17-Sep-2020 3:05 PM EDT
New York State Department of Health Grants Emergency Use Authorization to Mount Sinai for Quantitative COVID-19 Antibody Test
Mount Sinai Health System

The Clinical Laboratories of The Mount Sinai Hospital has received emergency use authorization from the New York State Department of Health (NYSDOH) for quantitative use of Mount Sinai’s COVID-19 antibody test, making Mount Sinai’s lab the first in the country to run an authorized, fully quantitative antibody test that can deliver a precise numeric measurement of the level of antibodies in a patient’s blood


Showing results

110 of 3321

close
0.93776